<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2024.14434</article-id>
<article-id pub-id-type="publisher-id">OL-28-1-14434</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Retracted] HCV‑E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Xiong</surname><given-names>Li</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhen</surname><given-names>Shuqing</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Yu</surname><given-names>Qionghua</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Gong</surname><given-names>Zuojiong</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>07</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>05</month>
<year>2024</year></pub-date>
<volume>28</volume>
<issue>1</issue>
<elocation-id>301</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2024 Xiong et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 14: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="14" page="2141" id="RA1" xlink:href="10.3892/ol.2017.6433" ext-link-type="doi">2141&#x2013;2146</related-article>, 2017; DOI: 10.3892/ol.2017.6433</p>
<p>Following the publication of this paper, it was drawn to the Editor&#x0027;s attention by a concerned reader that certain of the Transwell migration and invasion assay data shown in Fig. 4D on p. 2145 were strikingly similar to data that had already been published in different form in another article written by different authors at a different research institute [Feng L, Ma J, Li H, Liu Y and Hu W: MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2. Pathol Oncol Res 24: 853&#x2013;860, 2018].</p>
<p>Owing to the fact that the contentious data in the above article had already been published prior to its submission to <italic>Oncology Letters</italic>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>
